NEW YORK (GenomeWeb) – LexaGene announced today that it has partnered with Ethos Veterinary Health to test canine urine samples on LexaGene's LX6 prototype pathogen detection instrument.

Veterinarians at Ethos will send LexaGene clinically annotated urine samples for processing and pathogen detection on the LX6. The samples have been previously characterized using conventional technologies such as MALDI-TOF mass spectrometry at LexaGene's reference laboratory, the firm added.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.